Search Within

Mark E Robson

  1. "Molecular Imaging and Therapy Service"
Formats
  1. Journal Article (9)
  2. Meeting Abstract (3)
Groups
  1. Breast Medicine Service (12)
  2. Department of Medicine (12)
  3. Molecular Imaging and Therapy Service (12)
  4. Population Sciences Research Program (12)
  5. Solid Tumor Oncology Division (12)
  6. Survivorship Research (12)

More Groups

People
  1. Debra Mangino (5)
  2. Maxine Jochelson (4)
  3. Randy Yeh (4)
  4. Shanu Modi (4)
  5. Andreas Rimner (3)
  6. Andrew Seidman (3)

More People

Years
  1. 2024 (2)
  2. 2022 (1)
  3. 2021 (1)
  4. 2019 (2)
  5. 2018 (1)
  6. 2017 (4)

More Years

Publications
  1. Breast Cancer Research and Treatment (2)
  2. International Journal of Radiation Oncology, Biology, Physics (2)
  3. Clinical Cancer Research (1)
  4. European Journal of Radiology (1)
  5. European Radiology (1)
  6. JAMA Oncology (1)

More Publications

Publishers
  1. Springer (3)
  2. American Society of Clinical Oncology (2)
  3. Elsevier Inc. (2)
  4. American Association for Cancer Research (1)
  5. American Medical Association (1)
  6. Elsevier B.V (1)

More Publishers

Results (12)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • First-in-human evaluation of site-specifically labeled (89)Zr-pertuzumab in patients with HER2-positive breast cancer
    Journal Article

    Yeh, R.; O'Donoghue, J. A.; Jayaprakasam, V. S.; Mauguen, A.; Min, R.; Park, S.; Brockway, J. P.; Bromberg, J. F.; Zhi, W. I.; Robson, M. E.; more...
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): An open-label, randomised, controlled, phase 2 study
    Journal Article

    Tsai, C. J.; Yang, J. T.; Shaverdian, N.; Patel, J.; Shepherd, A. F.; Eng, J.; Guttmann, D.; Yeh, R.; Gelblum, D. Y.; Namakydoust, A.; more...
    Lancet (2024)

    Fulltext@MSK | Save
  • Final analysis of consolidative use of radiotherapy to block (CURB) oligoprogression trial - A randomized study of stereotactic body radiotherapy for oligoprogressive metastatic lung and breast cancers
    Meeting Abstract

    Tsai, C. J.; Yang, J. T.; Guttmann, D. M.; Shaverdian, N.; Eng, J.; Yeh, R.; Girshman, J.; Das, J.; Gelblum, D.; Xu, A. J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Consolidative use of radiotherapy to block (CURB) oligoprogression: Interim analysis of the first randomized study of stereotactic body radiotherapy in patients with oligoprogressive metastatic cancers of the lung and breast
    Meeting Abstract

    Tsai, C. J.; Yang, J. T.; Guttmann, D. M.; Shaverdian, N.; Shepherd, A. F.; Eng, J.; Gelblum, D.; Xu, A. J.; Namakydoust, A.; Iqbal, A.; more...
    International Journal of Radiation Oncology, Biology, Physics (2021)

    Fulltext@MSK | Save
  • Pilot study of rapid MR pancreas screening for patients with BRCA mutation
    Journal Article

    Corrias, G.; Raeside, M. C.; Agostini, A.; Huicochea-Castellanos, S.; Aramburu-Nunez, D.; Paudyal, R.; Shukla-Dave, A.; Smelianskaia, O.; Capanu, M.; Zheng, J.; more...
    European Radiology (2019)

    Fulltext@MSK | Save
  • Differences between screen-detected and interval breast cancers among BRCA mutation carriers
    Journal Article

    Pilewskie, M.; Zabor, E. C.; Gilbert, E.; Stempel, M.; Petruolo, O.; Mangino, D.; Robson, M.; Jochelson, M. S.
    Breast Cancer Research and Treatment (2019)

    Fulltext@MSK | Save
  • Differences between screen-detected and interval breast cancers among BRCA mutation carriers
    Meeting Abstract

    Pilewskie, M. L.; Zabor, E. C.; Stempel, M.; Petruolo, O.; Mangino, D.; Robson, M. E.; Jochelson, M. S.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Prospective genomic profiling of prostate cancer across disease states reveals germline and somatic alterations that may affect clinical decision making
    Journal Article

    Abida, W.; Armenia, J.; Gopalan, A.; Brennan, R.; Walsh, M.; Barron, D.; Danila, D.; Rathkopf, D.; Morris, M.; Slovin, S.; more...
    JCO Precision Oncology (2017)

    Fulltext@MSK | Save
  • Baseline surveillance in Li-Fraumeni syndrome using whole-body magnetic resonance imaging: A meta-analysis
    Journal Article

    Ballinger, M. L.; Best, A.; Mai, P. L.; Khincha, P. P.; Loud, J. T.; Peters, J. A.; Achatz, M. I.; Chojniak, R.; da Costa, A. B.; Santiago, K. M.; more...
    JAMA Oncology (2017)

    Fulltext@MSK | Save
  • Comparison of screening CEDM and MRI for women at increased risk for breast cancer: A pilot study
    Journal Article

    Jochelson, M. S.; Pinker, K.; Dershaw, D. D.; Hughes, M.; Gibbons, G. F.; Rahbar, K.; Robson, M. E.; Mangino, D. A.; Goldman, D.; Moskowitz, C. S.; more...
    European Journal of Radiology (2017)

    Fulltext@MSK | Save